Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.22.0.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total Shareholders Equity [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Oct. 31, 2020 $ 242 $ 200,355 $ (191,836) $ 8,761 $ (497) $ 8,264
Beginning balance, shares at Oct. 31, 2020 24,249          
Stock option compensation to employees and directors 875 875 875
Stock options and warrants issued to consultants 111 111 111
Common stock issued upon exercise of stock options 104 104 104
Common stock issued upon exercise of stock options, shares 30          
Common stock issued in at-the-market offering, net of offering expenses of $185 $ 20 5,937 5,957 5,957
Common stock issued in at-the-market offering, net of offering expenses, shares 1,900          
Net loss (2,208) (2,208) (24) (2,232)
Ending balance, value at Jan. 31, 2021 $ 262 207,382 (194,044) 13,600 (521) 13,079
Ending balance, shares at Jan. 31, 2021 26,179          
Beginning balance, value at Oct. 31, 2021 $ 301 239,927 (204,790) 35,438 (671) 34,767
Beginning balance, shares at Oct. 31, 2021 30,051          
Stock option compensation to employees and directors 2,135 2,135 2,135
Stock options and warrants issued to consultants 219 219 219
Common stock issued upon exercise of stock options and warrants
Common stock issued upon exercise of stock optionsand warrants, shares 81          
Net loss (3,829) (3,829) (50) (3,879)
Ending balance, value at Jan. 31, 2022 $ 301 $ 242,281 $ (208,619) $ 33,963 $ (721) $ 33,242
Ending balance, shares at Jan. 31, 2022 30,132